MDL Fonds is dedicated to creating a world free from gastrointestinal disorders, advocating for the health and well-being of over four million people in the Netherlands suffering from conditions related to the stomach, intestines, liver, esophagus, gallbladder, and pancreas. Formerly known as Maag Lever Darm Stichting, the rebranded MDL Fonds focuses on enhancing care, expanding resources, and improving the quality of life for patients.

The organization invests significantly in scientific research, supporting over 66 ongoing projects aimed at developing better treatments and new medications for a range of gastrointestinal diseases, such as Crohn's disease, ulcerative colitis, and bowel cancer. MDL Fonds also provides essential information about digestive health, nutrition, and lifestyle choices to promote a healthy gut.

As a fully donor-supported entity without any subsidies, MDL Fonds relies on contributions to fund its mission. They invite individuals and businesses to contribute through donations, sponsorships, and participation in fundraising events to support their vital work.